title: Anti-cytokeratin CAM 5.2 does not act as a surrogate of the cytokeratin 8/18 monoclonal antibody. Comment on: "Utility of p63 in the differential diagnosis of atypical fibroxanthoma and spindle cell squamous cell carcinoma", in J Cutan Pathol 2009; 36: 543.
authors.forename: Jih-Tseng
authors.initials: JT
authors.lastname: Chen
authors.forename: Jeng-Dong
authors.initials: JD
authors.lastname: Hsu
authors.forename: Chung-Chin
authors.initials: CC
authors.lastname: Yao
authors.forename: Lih-Wen
authors.initials: LW
authors.lastname: Han
authors.forename: Chih-Ping
authors.initials: CP
authors.lastname: Han
mesh_terms: D000911:Antibodies, Monoclonal; D015415:Biomarkers; D014408:Biomarkers, Tumor / Q000032:analysis; D006801:Humans; D007150:Immunohistochemistry / Q000379:methods / Q000592:standards*; D053538:Keratin-18 / Q000096:biosynthesis*; D053533:Keratin-8 / Q000096:biosynthesis*; D007633:Keratins / Q000096:biosynthesis*; D012878:Skin Neoplasms / Q000175:diagnosis* / Q000378:metabolism
chemical_list: D000911:Antibodies, Monoclonal; D015415:Biomarkers; D014408:Biomarkers, Tumor; C400901:CAM 5.2 antigen; D053538:Keratin-18; D053533:Keratin-8; D007633:Keratins